<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02620917</url>
  </required_header>
  <id_info>
    <org_study_id>3506/AO/15</org_study_id>
    <nct_id>NCT02620917</nct_id>
  </id_info>
  <brief_title>Continuos Subcutaneous Insulin Infusion in Italy</brief_title>
  <acronym>IMITA2</acronym>
  <official_title>Survey on Continuos Subcutaneous Insulin Infusion in Italy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Padova</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Padova</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is an observational, multicenter, cross sectional study, collecting clinical and
      metabolic informations about patients treated with CSII in Italy.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The aim of the study is to collect clinical and metabolic characteristics of patient treated
      with CSII in Italy.

      Data will be collected through a questionnaire sent by e-mail to CSII experienced Diabetes
      Centers ( both adult and pediatric patients) . The questionnaire assessed: (1) number of
      CSII-treated patients; (2) patients and pump characteristics; (3) structure and organization
      of Diabetes Centers providing CSII therapy; (4) metabolic control.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">November 2015</start_date>
  <completion_date type="Anticipated">December 1, 2017</completion_date>
  <primary_completion_date type="Anticipated">December 1, 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>efficacy assessed by mean of HbA1c,</measure>
    <time_frame>1 year</time_frame>
    <description>mean of HbA1c measured in the last year</description>
  </primary_outcome>
  <primary_outcome>
    <measure>safety assessed by number of severe hypoglycemia (requiring assistance by an other person) in the last year</measure>
    <time_frame>1year</time_frame>
    <description>number of severe hypoglycemia (requiring assistance by an other person) in the last year</description>
  </primary_outcome>
  <primary_outcome>
    <measure>efficacy assessed by number of patients with glycated hemoglobin value &lt; 7,5%</measure>
    <time_frame>1 yesr</time_frame>
    <description>number of patients with glycated hemoglobin value &lt; 7,5%</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>number of patients with HbA1c &lt;7,5% using advanced pump's functions, CGM and CHO counting</measure>
    <time_frame>1 year</time_frame>
    <description>number of patients with HbA1c &lt;7,5% using advanced pump's functions, CGM and CHO counting</description>
  </secondary_outcome>
  <enrollment type="Anticipated">10000</enrollment>
  <condition>Type 1 Diabetes</condition>
  <eligibility>
    <study_pop>
      <textblock>
        we will evaluate allItalian patients treated with insulin pump
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  all patients treated with CSIIin Italy

        Exclusion Criteria:
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Daniela Bruttomesso, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Padova</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Padova</name>
      <address>
        <city>Padova</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>April 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 23, 2015</study_first_submitted>
  <study_first_submitted_qc>November 30, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 3, 2015</study_first_posted>
  <last_update_submitted>October 3, 2017</last_update_submitted>
  <last_update_submitted_qc>October 3, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">October 4, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Padova</investigator_affiliation>
    <investigator_full_name>Daniela Bruttomesso</investigator_full_name>
    <investigator_title>MD medical doctor, PhD</investigator_title>
  </responsible_party>
  <keyword>type 1 diabetes</keyword>
  <keyword>CSII</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus, Type 1</mesh_term>
  </condition_browse>
  <pending_results>
    <submitted>January 12, 2018</submitted>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

